Aperam S.A.
APEMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.54 | -0.18 | -0.11 | 0.01 |
| FCF Yield | 6.83% | 7.16% | 15.59% | 10.46% |
| EV / EBITDA | 6.71 | 7.87 | 2.81 | 3.57 |
| Quality | ||||
| ROIC | 8.68% | 3.29% | 15.91% | 22.36% |
| Gross Margin | 7.18% | 5.01% | 14.47% | 24.17% |
| Cash Conversion Ratio | 2.17 | 2.32 | 1.03 | 0.57 |
| Growth | ||||
| Revenue 3-Year CAGR | -8.47% | 8.92% | 31.05% | 6.36% |
| Free Cash Flow Growth | -26.47% | -50.87% | -13.07% | 105.15% |
| Safety | ||||
| Net Debt / EBITDA | 1.54 | 1.35 | 0.49 | 0.39 |
| Interest Coverage | 2.74 | 2.07 | 40.45 | 104.20 |
| Efficiency | ||||
| Inventory Turnover | 2.69 | 2.75 | 2.69 | 1.66 |
| Cash Conversion Cycle | 106.02 | 90.84 | 95.08 | 147.21 |